Upfront Combination of Statin and Ezetimibe for Patients With Acute Coronary Syndrome: Time for a New Approach?
- PMID: 37671619
- PMCID: PMC10547264
- DOI: 10.1161/JAHA.123.031615
Upfront Combination of Statin and Ezetimibe for Patients With Acute Coronary Syndrome: Time for a New Approach?
Keywords: Editorials; acute coronary syndrome; ezetimibe; lipid lowering therapy; statin.
Comment on
-
Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL-ACS Data.J Am Heart Assoc. 2023 Sep 19;12(18):e030414. doi: 10.1161/JAHA.123.030414. Epub 2023 Sep 6. J Am Heart Assoc. 2023. PMID: 37671618 Free PMC article.
References
-
- Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella‐Tommasino J, Forman DE, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082–e1143. doi: 10.1161/CIR.0000000000000625 - DOI - PMC - PubMed
-
- Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Oka H, Nakao K, et al. Impact of dual lipid‐lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: the multicenter randomized controlled PRECISE‐IVUS trial. J Am Coll Cardiol. 2015;66:495–507. doi: 10.1016/j.jacc.2015.05.065 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical